Your browser doesn't support javascript.
loading
Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors / 南方医科大学学报
Journal of Southern Medical University ; (12): 39-43, 2016.
Article Dans Chinois | WPRIM | ID: wpr-232514
ABSTRACT
<p><b>OBJECTIVE</b>To characterize the clinical features of desmoid tumor, assess the efficacy of conservative chemotherapy for inoperable desmoid tumor and analyze the prognostic factors.</p><p><b>METHODS</b>From August 2009 to December 2013, 52 patients with inoperable desmoid tumor were treated in our department and received chemotherapy with vinorelbine combined with low-dose methotrexate. The clinical data of the patients were analyzed retrospectively.</p><p><b>RESULTS</b>The patients studied included 22 male and 30 female patients with the age of disease onset ranging from 2 to 46 years (mean 18.7 years). The lesions occurred most frequently in the lower limbs (36.5%, 19/52) and the tumor size ranged from 2.7 to 37 cm (mean 9.5 cm). The patients were followed up for a median of 29 months (7 to 64 months). The chemotherapy lasted for 4 to 30 months (median 12 months). After completion of the chemotherapy, 1 patient had a complete response (CR), 18 showed partial responses (PR), 27 cases had stable disease (SD), and 6 had progressive disease (PD), with an overall response rate (ORR) of 88.5%. The progression-free survival (PFS) time of the patients ranged from 4 to 63 months (median 26.5 months) with a 2-year PFS rate of 76.7% and 5-year PFS rate of 41.9%. A longer chemotherapy duration (over 12 months) was associated with a more favorable prognosis. No significant differences in PFS were found between the patients stratified by gender, age of disease onset, age when receiving chemotherapy, tumor site, or tumor size.</p><p><b>CONCLUSION</b>For recurrent, inoperable and progressive desmoid tumor, long enough cycles of vinorelbine combined with low-dose methotrexate can be an effective and safe option for tumor control.</p>
Sujets)
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Pronostic / Vinblastine / Protocoles de polychimiothérapie antinéoplasique / Méthotrexate / Études rétrospectives / Fibromatose agressive / Survie sans rechute / Utilisations thérapeutiques / Traitement médicamenteux Type d'étude: Étude observationnelle / Étude pronostique Limites du sujet: Adolescent / Adulte / Enfant / Enfant d'âge préscolaire / Femelle / Humains / Mâle langue: Chinois Texte intégral: Journal of Southern Medical University Année: 2016 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Pronostic / Vinblastine / Protocoles de polychimiothérapie antinéoplasique / Méthotrexate / Études rétrospectives / Fibromatose agressive / Survie sans rechute / Utilisations thérapeutiques / Traitement médicamenteux Type d'étude: Étude observationnelle / Étude pronostique Limites du sujet: Adolescent / Adulte / Enfant / Enfant d'âge préscolaire / Femelle / Humains / Mâle langue: Chinois Texte intégral: Journal of Southern Medical University Année: 2016 Type: Article